Casey's General Stores (CASY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Allstate (ALL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
BHP (BHP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Investors might want to bet on AppFolio (APPF), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Investors might want to bet on Billiton (BBL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key
Amerisafe, Inc. AMSF has been exhibiting a strong operating performance, which reflects on its better-than-expected underwriting results for the past many years. The results were driven by a favorable prior-year reserve development.
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to disco
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, gr
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
International Business Machines Corporation IBM will be leveraging the AI capabilities of Watson to enrich ESPN Fantasy Football experience for gamers.
Nvidia Corp's $40 billion acquisition of chip designer Arm is set to catapult it into the fray of geopolitical tensions between Beijing and Washington, analysts and lawyers say.
Novartis NVS reported positive results from the phase III KITE study on ophthalmology drug, Beovu (brolucizumab).The ongoing two-year study is assessing the efficacy and safety of Beovu 6 mg in diabetic macular edema (DME). The study met its primary and key secondary endpoints,
FTI Consulting, Inc.’s FCN shares have gained 4.3% over the past three months and we expect this rally to accelerate going forward as the company improves upon its top- and bottom-line growth.
Pfizer Inc. PFE and Germany-based biotech partner BioNTech SE BNTX announced that they have submitted an amended protocol for their late-stage pivotal study evaluating their coronavirus vaccine candidate, BNT162b2, to the FDA for approval. Per the amended protocol, the companies
Checked
22 minutes 42 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks